Author Archives: Health

ESC: Eli Lilly, Boehringer’s Jardiance cuts CV events by 25% in Farxiga-matching heart failure trial

AstraZeneca put the rest of the SGLT2 inhibitor class on notice when its Farxiga scored an FDA heart failure nod in patients with or without diabetes. One of its competitors, Eli Lilly and Boehringer Ingelheim’s Jardiance, is fast on Farxiga’s heels, though, and it’s ready to bring its pivotal trial win in front of physicians.  Jardiance, added… Read More »

Phase 1 human trials suggest breast cancer drug is safe, effective

A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy. The results are published in the journal Breast… Read More »

Telehealth Use Among Older Americans: Growing Interest, Remaining Concerns

In the Fear of Going Out Era spawned by the COVID-19 pandemic, many patients were loath to go to the doctor’s office for medical care, and even less keen on entering a hospital clinic’s doors. This drove health consumers to virtual care platforms in the first months of the public health crisis — including lots… Read More »